- Home
- LPRO vs STIM Comparison
LPRO vs STIM Comparison
Compare LPRO & STIM Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- LPRO
- STIM
- Stock Information
- Founded
- LPRO 2000
- STIM 2003
- Country
- LPRO United States
- STIM United States
- Employees
- LPRO N/A
- STIM N/A
- Industry
- LPRO Finance: Consumer Services
- STIM Medical/Dental Instruments
- Sector
- LPRO Finance
- STIM Health Care
- Exchange
- LPRO Nasdaq
- STIM Nasdaq
- Market Cap
- LPRO 232.4M
- STIM 232.3M
- IPO Year
- LPRO N/A
- STIM 2018
- Fundamental
- Price
- LPRO $2.45
- STIM $3.56
- Analyst Decision
- LPRO Buy
- STIM Buy
- Analyst Count
- LPRO 6
- STIM 4
- Target Price
- LPRO $3.44
- STIM $6.00
- AVG Volume (30 Days)
- LPRO 1.3M
- STIM 950.0K
- Earning Date
- LPRO 08-07-2025
- STIM 08-11-2025
- Dividend Yield
- LPRO N/A
- STIM N/A
- EPS Growth
- LPRO N/A
- STIM N/A
- EPS
- LPRO N/A
- STIM N/A
- Revenue
- LPRO $17,672,000.00
- STIM $89,448,000.00
- Revenue This Year
- LPRO $314.67
- STIM $105.22
- Revenue Next Year
- LPRO $15.32
- STIM $11.89
- P/E Ratio
- LPRO N/A
- STIM N/A
- Revenue Growth
- LPRO N/A
- STIM 22.16
- 52 Week Low
- LPRO $0.70
- STIM $0.52
- 52 Week High
- LPRO $6.92
- STIM $5.92
- Technical
- Relative Strength Index (RSI)
- LPRO 65.26
- STIM 46.24
- Support Level
- LPRO $2.20
- STIM $3.18
- Resistance Level
- LPRO $2.56
- STIM $3.60
- Average True Range (ATR)
- LPRO 0.16
- STIM 0.21
- MACD
- LPRO 0.04
- STIM 0.03
- Stochastic Oscillator
- LPRO 84.67
- STIM 86.00
About LPRO Open Lending Corporation
Open Lending Corp is engaged in providing automated lending services to financial institutions. The company offers loan analytics, risk-based pricing, risk modeling, and automated decision technology. Its Lenders Protection Program ("LPP") enables automotive lenders to make loans that are largely insured against, losses from defaults.
About STIM Neuronetics Inc.
Neuronetics Inc a commercial stage medical technology company focused on designing, developing and marketing products that improve the quality of life for patients who suffer from psychiatric disorders. Its first commercial product, the NeuroStar Advanced Therapy System, is a non-invasive and non-systemic office-based treatment that uses transcranial magnetic stimulations, or TMS, to create a pulsed, MRI-strength magnetic field that induces electrical currents designed to stimulate specific areas of the brain associated with mood. The company designed the NeuroStar Advanced Therapy as a non-invasive therapeutic alternative to treat patients who suffer from MDD and to address many of the key limitations of existing treatment options.